Dotatate to Locate Coronary Plaques at High-risk of Myocardial Infarction

Inclusion Criteria: * Aged 50 years and older * Underwent CCTA imaging within 78 weeks from the screening visit * Either CAD-RADS 4 or higher or 0/1 on CCTA. * Able to provide written informed consent Exclusion Criteria: * History of chronic kidney disease stage 3b - 5, defined as a CKD-EPI value of \< 45 ml/min/1,73m2. * CVD events/revascularization in history * Malignant diseases or any clinically significant medical condition that could interfere with the conduct of the study in the opinion of the investigator. * Chronic or recent (\< 1 month) infections and/or clinical signs of acute infection. * History of auto-immune diseases. * Standard contra-indications to 68Ga-Dotatate PET, and CT based on physicians experience and current practices. * Inability or unwillingness to comply with the protocol requirements, or deemed by investigator to be unfit for the study. * Elevated liver enzymes (\> 2 ULN of liver transaminases), acute liver failure or known liver disease.